Title |
Rescue strategy in cardiogenic shock: emergency transcatheter aortic valve implantation for failed bioprosthetic valve – case report / |
Translation of Title |
Gelbėjimo strategija esant kardiogeniniam šokui: neatidėliotinas perkateterinis aortos vožtuvo implantavimas dėl biologinio vožtuvo nepakankamumo – gydymo atvejis. |
Authors |
Kundelis, Ričardas ; Bajoras, Vilhelmas ; Čėsna, Sigitas ; Davidavičius, Giedrius |
DOI |
10.15388/Amed.2025.32.1.1 |
Full Text |
|
Is Part of |
Acta medica Lituanica.. Vilnius : Vilniaus universiteto leidykla. 2025, vol. 32, no. 1, p. 5-10.. ISSN 1392-0138. eISSN 2029-4174 |
Keywords [eng] |
TAVI ; transcatheter aortic valve implantation ; bioprosthetic valve failure ; cardiogenic shock |
Abstract [eng] |
Background: Transcatheter aortic valve implantation (TAVI) has emerged as an essential therapeutic intervention for patients with severe aortic valve disease, providing a less invasive alternative to traditional surgery, particularly in high-risk individuals. TAVI is also increasingly utilized as a valve-in-valve strategy in cases of a bioprosthetic valve failure. However, data on the efficacy of TAVI in the context of a hemodynamic collapse remain limited. Methods: This report represents a young, high-risk patient with a failed bioprosthetic valve and cardiogenic shock treated successfully with TAVI. Results: Emergency TAVI using a Medtronic Evolut Pro+ device achieved rapid hemodynamic stabilization and favorable post-procedural clinical and functional outcomes. Intermittent complete atrioventricular block necessitated the implantation of a permanent pacemaker. Conclusions: This case highlights the potential of TAVI as a safe and effective intervention in critical clinical scenarios. Emergency TAVI is a viable therapeutic intervention for patients with failed surgical bioprostheses presenting with cardiogenic shock. |
Published |
Vilnius : Vilniaus universiteto leidykla |
Type |
Journal article |
Language |
English |
Publication date |
2025 |
CC license |
|